Cite
MLA Citation
M. Franken et al.. “2119 Capecitabine and bevacizumab (CB) maintenance treatment in metastatic colorectal cancer (mCRC): A cost-effectiveness analysis.” European journal of cancer, vol. 51, n.d., pp. S370–. http://access.bl.uk/ark:/81055/vdc_100030628213.0x000036